Previously, we compared fixed low doses of heparin with adjusted doses of warfarin for the long-term treatment of venous thrombosis; in that study low-dose heparin was ineffective in preventing recurrence in patients with proximal-vein thrombosis. We have now completed a randomized trial comparing adjusted doses of heparin and of warfarin for prevention of recurrent venous thromboembolism in patients with proximal-vein thrombosis. One hundred six consecutive patients with acute proximal-vein thrombosis confirmed by venography were treated with intravenous heparin and then randomized to secondary prophylaxis. Two of 53 patients receiving heparin, as compared with one of 53 receiving warfarin, had new episodes of objectively documented venous thromboembolism. Nine patients taking warfarin had bleeding complications (which were major in three patients), as compared with one patient taking heparin (P = 0.008). Our data indicate that adjusted-dose subcutaneous heparin therapy provides an effective alternative to warfarin sodium and is associated with a lower risk of bleeding.
This article has been cited by other articles:
Schulman, S., Beyth, R. J., Kearon, C., Levine, M. N.
(2008). Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 257S-298S
[Abstract][Full Text]
Kearon, C., Kahn, S. R., Agnelli, G., Goldhaber, S., Raskob, G. E., Comerota, A. J.
(2008). Antithrombotic Therapy for Venous Thromboembolic Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 454S-545S
[Abstract][Full Text]
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., Hirsh, J.
(2008). Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest
133: 844S-886S
[Abstract][Full Text]
Spyropoulos, A. C.
(2008). Outpatient-Based Primary and Secondary Thromboprophylaxis With Low-Molecular-Weight Heparin. CLIN APPL THROMB HEMOST
14: 63-74
[Abstract]
Cronin, C. G., Lohan, D. G., Keane, M., Roche, C., Murphy, J. M.
(2007). Prevalence and Significance of Asymptomatic Venous Thromboembolic Disease Found on Oncologic Staging CT. Am. J. Roentgenol.
189: 162-170
[Abstract][Full Text]
Cirujeda, J. L., Granado, P. C.
(2006). A Study on the Safety, Efficacy, and Efficiency of Sulodexide Compared with Acenocoumarol in Secondary Prophylaxis in Patients with Deep Venous Thrombosis. ANGIOLOGY
57: 53-64
[Abstract]
Cham, M. D., Yankelevitz, D. F., Henschke, C. I.
(2005). Thromboembolic Disease Detection at Indirect CT Venography versus CT Pulmonary Angiography. Radiology
234: 591-594
[Abstract][Full Text]
McGuire, M., Dobesh, P. P.
(2004). Therapeutic Update on the Prevention and Treatment of Venous Thromboembolism. Journal of Pharmacy Practice
17: 289-307
[Abstract]
Levine, M. N., Raskob, G., Beyth, R. J., Kearon, C., Schulman, S.
(2004). Hemorrhagic Complications of Anticoagulant Treatment: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 287S-310S
[Abstract][Full Text]
Buller, H. R., Agnelli, G., Hull, R. D., Hyers, T. M., Prins, M. H., Raskob, G. E.
(2004). Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 401S-428S
[Abstract][Full Text]
Bates, S. M., Greer, I. A., Hirsh, J., Ginsberg, J. S.
(2004). Use of Antithrombotic Agents During Pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest
126: 627S-644S
[Abstract][Full Text]
Kearon, C.
(2004). Long-Term Management of Patients After Venous Thromboembolism. Circulation
110: I-10-I-18
[Abstract][Full Text]
van Dongen, C. J. J., Vink, R., Hutten, B. A., Buller, H. R., Prins, M. H.
(2003). The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event: A Meta-analysis. Arch Intern Med
163: 1285-1293
[Abstract][Full Text]
Hirsh, J., Fuster, V., Ansell, J., Halperin, J. L.
(2003). American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. J Am Coll Cardiol
41: 1633-1652
[Full Text]
Hirsh, J., Fuster, V., Ansell, J., Halperin, J. L.
(2003). American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy. Circulation
107: 1692-1711
[Full Text]
Ginsberg, J. S., Chan, W. S., Bates, S. M., Kaatz, S.
(2003). Anticoagulation of Pregnant Women With Mechanical Heart Valves. Arch Intern Med
163: 694-698
[Abstract][Full Text]
Kher, A., Samama, M.M.
(2001). Low-Molecular-Weight Heparins: Weeks or Months Instead of Days of Treatment. CLIN APPL THROMB HEMOST
7: 314-320
[Abstract]
Hirsh, J., Dalen, J. E., Anderson, D. R., Poller, L., Bussey, H., Ansell, J., Deykin, D.
(2001). Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range. Chest
119: 8S-21S
[Full Text]
Levine, M. N., Raskob, G., Landefeld, S., Kearon, C.
(2001). Hemorrhagic Complications of Anticoagulant Treatment. Chest
119: 108S-121S
[Full Text]
Ginsberg, J. S., Greer, I., Hirsh, J.
(2001). Use of Antithrombotic Agents During Pregnancy. Chest
119: 122S-131S
[Full Text]
Hyers, T. M., Agnelli, G., Hull, R. D., Morris, T. A., Samama, M., Tapson, V., Weg, J. G.
(2001). Antithrombotic Therapy for Venous Thromboembolic Disease. Chest
119: 176S-193S
[Full Text]
Cham, M. D., Yankelevitz, D. F., Shaham, D., Shah, A. A., Sherman, L., Lewis, A., Rademaker, J., Pearson, G., Choi, J., Wolff, W., Prabhu, P. M., Galanski, M., Clark, R. A., Sostman, H. D., Henschke, C. I.
(2000). Deep Venous Thrombosis: Detection by Using Indirect CT Venography. Radiology
216: 744-751
[Abstract][Full Text]
Hull, R. D., Raskob, G. E., Brant, R. F., Pineo, G. F., Elliott, G., Stein, P. D., Gottschalk, A., Valentine, K. A., Mah, A. F., for the American-Canadian Thrombosis Study Group,
(2000). Low-Molecular-Weight Heparin vs Heparin in the Treatment of Patients With Pulmonary Embolism. Arch Intern Med
160: 229-236
[Abstract][Full Text]
Noel, A. A., Pappas, P. J., Haser, P. B., Silva, M. B. JR, Hobson, R. W.
(1998). Experience with Greenfield Filters in Pregnant Women for Deep Venous Thrombosis and Pulmonary Embolism Case Reports. VASC ENDOVASCULAR SURG
32: 367-372
[Abstract]
Douketis, J. D., Kearon, C., Bates, S., Duku, E. K., Ginsberg, J. S.
(1998). Risk of Fatal Pulmonary Embolism in Patients With Treated Venous Thromboembolism. JAMA
279: 458-462
[Abstract][Full Text]
Ridker, P. M, PREVENT Investigators,
(1998). Long-term, low-dose warfarin among venous thrombosis patients with and without factor V Leiden mutation: rationale and design for the Prevention of Recurrent Venous Thromboembolism (PREVENT) trial. Vasc Med
3: 67-73
[Abstract]
Valentine, K. A., Hull, R. D., Pineo, G. F.
(1998). Low-Molecular-Weight Heparin Therapy and Mortality. PERSPECT VASC SURG ENDOVASC THER
9: 99-108
[Abstract]
Becker, R. C., Ansell, J.
(1997). The Need for Long-Term Anticoagulants in Venous Thromboembolism: How Long?. CLIN APPL THROMB HEMOST
3: S8-S15
Johnson, M.
(1997). Problems of anticoagulation within a palliative care setting: an audit of hospice patients taking warfarin. Palliat Med
11: 306-312
[Abstract]
Diuguid, D. L.
(1997). Oral Anticoagulant Therapy for Venous Thromboembolism. NEJM
336: 433-434
[Full Text]
McCrae, K.
(1996). Antiphospholipid antibody associated thrombosis: A consensus for treatment?. Lupus
5: 560-570
[Abstract]
Toglia, M. R., Weg, J. G.
(1996). Venous Thromboembolism during Pregnancy. NEJM
335: 108-114
[Full Text]
Hirsh, J., Hoak, J.
(1996). Management of Deep Vein Thrombosis and Pulmonary Embolism : A Statement for Healthcare Professionals From the Council on Thrombosis (in Consultation With the Council on Cardiovascular Radiology), American Heart Association. Circulation
93: 2212-2245
[Full Text]
Ridker, P. M., Miletich, J. P., Stampfer, M. J., Goldhaber, S. Z., Lindpaintner, K., Hennekens, C. H.
(1995). Factor V Leiden and Risks of Recurrent Idiopathic Venous Thromboembolism. Circulation
92: 2800-2802
[Abstract][Full Text]
Mirande, R. A., Mirande, K. K., Liu, T., Baker, W. H.
(1995). Inferior Vena Caval Filter Placement Without Preoperative Venacavography. VASC ENDOVASCULAR SURG
29: 469-475
[Abstract]
Schulman, S., Rhedin, A.-S., Lindmarker, P., Carlsson, A., Larfars, G., Nicol, P., Loogna, E., Svensson, E., Ljungberg, B., Walter, H., Viering, S., Nordlander, S., Leijd, B., Jonsson, K.-A., Hjorth, M., Linder, O., Boberg, J., The Duration of Anticoagulation Trial Study Group,
(1995). A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism. NEJM
332: 1661-1665
[Abstract][Full Text]
Hirsh, J.
(1995). The Optimal Duration of Anticoagulant Therapy for Venous Thrombosis. NEJM
332: 1710-1712
[Full Text]
Hull, R. D., Raskob, G. E., Pineo, G. F., Brant, R. F.
(1995). The Treatment of Proximal Vein Thrombosis with Subcutaneous Low-Mole Molecular-Weight Heparin Compared with Continuous Intravenous Heparin. CLIN APPL THROMB HEMOST
1: 151-159
[Abstract]
Baker, W. F. JR
(1995). Outcome Analysis for Treatment in 100 Patients with Deep Vein Thrombosis. CLIN APPL THROMB HEMOST
1: 39-48
[Abstract]
Seed, W.
(1991). Pulmonary embolism: Part 1. Vasc Med
2: 71-83
Hollingsworth, H. M., Pratter, M. R., Irwin, R. S.
(1989). Acute Respiratory Failure in Pregnancy. J Intensive Care Med
4: 11-34
[Abstract]
